ロード中...
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
Background: Cabozantinib, a multiple kinase inhibitor, was recently approved for patients with previously treated unresectable hepatocellular carcinoma (uHCC). We investigated the real-world safety and efficacy profiles of cabozantinib. Methods: This multicenter retrospective study included 110 pati...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2022-05-01
|
| シリーズ: | Therapeutic Advances in Medical Oncology |
| オンライン･アクセス: | https://doi.org/10.1177/17588359221097934 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|